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Overview
• Translational Science
• Why?
• What?
• The translational spectrum: a changing nomenclature
• “Bench to beside”: a limited paradigm 
• Wrong endpoint (bedside)
• Wrong direction: what about “bedside” to bench? 
• Charge for the day 
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Why Translational Science? 
• Median time from description of a new 
discovery in a basic science journal to 
publication of use of this discovery in a highly 
cited article in the medical literature: 24 years
• Contopoulus-Ioannidis, Science, Sept 2008
• Mean time  to implement a new clinical 
research finding into practice: 17 years
• Balas, Boren, Yearbook Medical Informatics, 2000
Copyright restrictions may apply.
Sung, N. S. et al. JAMA 2003;289:1278-1287.
Translational Blocks in the Clinical Research 
Continuum
5
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Translational Research in US
 Introduced as part of NIH Roadmap
◦ Zerhouni . The NIH Roadmap. Science 2003 (302:63-72)
NIH Definitions used in CTSA funding  (e.g. RFA-RM-10-020)
◦ Clinical research comprises studies and trials in human 
subjects
◦ Translational research includes two areas of 
translation:
 Applying findings from laboratory research and preclinical 
studies to the development of trials and studies in humans
 Enhancing the adoption of best practices in the community 
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Translational Research in Europe
• UK Cooksey Report: 
• Process of taking the findings of either basic or clinical 
research to produce innovations in health care settings 
Cooksey 2006. The Stationery Office. London
• The European Advanced Translational 
Research Infrastructure in Medicine (EATRIS) 
Becker and vanDongen.  J Cardiovasc Trans Res 2011 
• Funded in part by European Union, to be established 
through both public and private funds 
• “Maintain Europe's competitiveness in biomedical 
research and health industry”
8Adapted from Waldman and Terzic. Clin Transl Sc 2010  3(5): 254-7
9Adapted from Waldman and Terzic. Clin Transl Sc 2010  3(5): 254-7
10Adapted from Waldman and Terzic. Clin Transl Sc 2010 3(5): 254-7
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The Broad Spectrum of Biomedical 
Research: Genomics Khoury et al. Genet Med 2007:9(10):665-74
• T0: Genome
• T1: Moves genome-based discovery into candidate health 
application (eg genetic tests)
• T2: Assesses value of application for health practice, leads to 
evidence-based guidelines
• T3: Moves guidelines/evidence into practice
• T4: Evaluates “real world” health outcomes of genomic 
applications
• T5: Studies genomics in the context of the social 
determinants of health
• <3% of genomic research focuses on T2 – T5
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T1 vs. T2+:  Changing Boundaries 
• Initially, translational research required 
“whole humans” or human population groups 
as study units. Evolving nomenclature: 
• T1 research takes knowledge from the bench 
(“wet lab”) to clinical knowledge
• Initially: Phase1-3 clinical trial (including RCTs)
• Recently: also “T0”, mice, even cells…
• T2+  research takes clinical knowledge into 
realized human benefit
• E.g. Group-randomized implementation trials
• Recently: also phase 3 clinical trials
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T1 versus T2+ Research
• T2+  defining elements:
• “dry lab” research that uses statistics and epidemiology as 
its   basic tools
• The study units may be individual humans,  groups of 
humans (populations), or health systems
• T1 defining elements: 
• May also use “wet lab” tools but used to  involve “whole 
humans” 
• Study unit now from lab animal to individual patient
• Cultural  innovations for both:
• Transdisciplinary, team science
• Bidirectionality as emerging concept
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Overview
Translational Science
Why?
What?
The translational spectrum: a changing nomenclature
• “Bench to beside”: a limited paradigm 
• Wrong endpoint (bedside)
• Wrong direction: what about “bedside” to 
bench? 
• Charge for the day 
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Example : Type 2 Diabetes 
Prevention
• Chronic hyperglycemia causes severe end-
organ damage through fairly well 
understood pathopysiology (T0, T1)
• T0-T1 research has resulted in multiple 
medications  that control hyperglycemia 
• Solid clinical research links Type 2 diabetes 
to overweight/obesity (T2 - T3): the 
diabesity epidemic 
Why T2+ Research? 
16
•The diabesity epidemic
Freedman MMWR  2011
With a 
parallel 
rise in the 
incidence 
of diabetes
Prevalence of obesity among men  in the US  
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Important  Translational Question
• Weight loss and other lifestyle modifications 
improve glucose control in patients with 
diabetes
• Can lifestyle modification and weight 
reduction  PREVENT diabetes? 
17
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Diabetes Prevention Program (DPP)
• RCT : 3,234 persons at 27 centers, followed 
for 10 years Knowler, NEJM 2002; Knowler, Lancet 2009 
• Cumulative incidence of DM2 lowest in 
lifestyle group: 
• 58% lower incidence at 1 year 
• 34% lower incidence at 10 years 
• Classical  efficacy study (T1 –T2) 
• Oral GTT as the screening tool
• Very intensive, expensive one-on-one intervention
• Educated population, all literate
• Overweight/obesity assumed important mediator 
18
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Why Research Beyond the 
“classical” RCT? 
• DPP efficacy study notwithstanding, diabesity
epidemic marches on
• Lawrence Latino “DPP” (LLDPP)
• community-based effectiveness study – “real world” 
• 252 at risk pts randomized 
• Group-based less intensive intervention
• Inexpensive
• 30 % of population illiterate in Spanish and English
DPP vs. LLDPP outcomes at 1 year 
Improvements  in Outcomes at 1 year *
DPP LDPPP
Weight (lbs) 17 3.1
HgbA1c (%) 0.1 0.1
* Numbers approximate; personal communication from I Ockene 
20
Why similar effect of intervention on  
hyperglycemia, yet much weaker 
effect on weight???? 
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Why different effects 
LLDDP vs. DPP? 
• Efficacy vs. effectiveness study?
• But effect on HgbA1c  was similar
• Different populations? 
• Some Latino groups, Native Americans know to 
be exquisitely sensitive to weight gain   re 
diabetes incidence
• Are we seeing reverse effect here? 
• Need to investigate mechanism that underlies 
these differences: genetics ? 
Bidirectionality
• Should our approach remain linear?
OR
• Should transdisciplinary teams  implement true 
bidirectionality? 
22
T0            T1          T2           T3           T4             T5
Team Science,  Bidirectionality
Population Health
Molecules
Health Care
23
T0
T1
T2T3
T4
T5
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3 Historical Examples of 
Bidirectionality    
Rutter and Plomin, Psychol Med 2009
• Tobacco and lung cancer
• First: Epidemiologic studies Doll and Hill, BMJ 1950 and 1954
• Later: clinical  and animal studies, then gene expression studies Wen, Mod Path 2011
• Lipids and heart disease 
• Initial rabbit studies ignored (1913)
• Epidemiologic evidence in 1956
• Basic lab research in „70s: model of how LDL causes atherosclerotic  lesions
• LRC trial in the 80s, large statin RCTs in 90‟s 
• Fetal alcohol syndrome 
• Clinical observations define syndrome Kl Jones, Lancet 1973
• Mice studies confirm 
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SUMMARY
• Translational research is 
• Transdisciplinary
• Bidirectional 
• Driven by the need to move from knowledge for 
the sake of knowledge  to realized human benefit
• Reminds us that 
“Science without conscience is the soul‟s 
perdition” Rabelais, Pantagruel, 1572
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QUESTIONS?????
Charge for the Day
• Look for bidirectionality
• Keynote lecture
• Mini-symposia
• Posters
• Think transdisciplinary teams 
• Next presentation, lunch, coffee breaks  
• Tell us how to do better
• Fill-out evaluations
• HAVE FUN
• All day long and evening reception with posters
• 5 prizes for best posters at evening reception  
